JAC Advance Access originally published online on April 13, 2007
Journal of Antimicrobial Chemotherapy 2007 59(6):1148-1154; doi:10.1093/jac/dkm088
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Modified guidelines impact on antibiotic use and costs: duration of treatment for pneumonia in a neurosurgical ICU is reduced
1 Institute of Environmental Medicine and Hospital Epidemiology, Freiburg University Hospital, Hugstetter Str. 55, 79106 Freiburg, Germany 2 Department of Neurosurgery, Freiburg University Hospital, Freiburg, Germany 3 Department for Medical Microbiology and Hygiene, Freiburg University Hospital, Freiburg, Germany 4 Hospital Pharmacy, Freiburg University Hospital, Freiburg, Germany 5 Institute of Medical Microbiology and Hospital Epidemiology, Hannover School of Medicine, Germany 6 National Reference Centre for Surveillance of Nosocomial Infections, Germany 7 Institute of Hygiene and Environmental Medicine, Charité—University Medicine Berlin, Germany
Received 23 January 2007; returned 1 February 2007; revised 2 March 2007; accepted 4 March 2007
* Corresponding author. Tel: +49-761-270-5487; Fax: +49-761-270-5485; E-mail: elisabeth.meyer{at}uniklinik-freiburg.de
Objectives: To evaluate the impact of an intervention to reduce the duration of antibiotic treatment for pneumonia in a neurosurgical intensive care unit (ICU). The usage of antibiotics and the resultant costs were examined using interrupted time series analysis while resistance and device-associated infection rates are also described.
Methods: In January 2004, revised guidelines for the use of antibiotics were implemented. As a consequence of this, the duration of antibiotic therapy for nosocomial pneumonia was reduced from 14 to 7 days, while for community-acquired pneumonia the period fell from 10 to 5 days. The effect on the antibiotic use density [AD; expressed as defined daily doses (DDD) per 1000 patient days (pd)] was calculated by segmented regression analysis of interrupted time series for the 24 months prior to (2002 and 2003) and after the intervention (2004 and 2005).
Results: The intervention was associated with a significant decrease in total AD from 949.8 to 626.7 DDD/1000 pd after the intervention. This was mainly due to reduced consumption of second-generation cephalosporins (–100.6 DDD/1000 pd), imidazoles (– 100.3 DDD/1000 pd), carbapenems (–33.3 DDD/1000 pd), penicillins with ß-lactamase inhibitor (–33.5 DDD/1000 pd) and glycopeptides (–30.2 DDD/1000 pd). Glycopeptide reduction might be associated with a significant decrease in the proportion of methicillin-resistant Staphylococcus aureus (8.4% before and 2.9% after the intervention). Similarly, total antibiotic costs/pd (
) showed a significant decrease from 13.16 /pd before to 7.31 /pd after the intervention. This is a saving of 5.85 /pd. The incidence of patients dying with pneumonia did not change significantly.
Conclusions: The most conservative estimate of segmented regression analysis over a 48 month period showed that halving the duration of treatment for pneumonia results in a reduction of over 30% in antibiotic consumption and costs. Because respiratory infections are most common in ICU patients, interventions targeting a reduction in the duration of treatment of pneumonia might be extremely worthwhile.
Keywords: intensive care units , duration of antibiotic treatment , costs , segmented regression analysis , interrupted time series
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  N. Vernaz, H. Sax, D. Pittet, P. Bonnabry, J. Schrenzel, and S. Harbarth Temporal effects of antibiotic use and hand rub consumption on the incidence of MRSA and Clostridium difficile J. Antimicrob. Chemother., September 1, 2008; 62(3): 601 - 607. [Abstract] [Full Text] [PDF]
|
|